NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Neuroone Medical Technologies's price to book ratio was 1.9× on Nov 11, 2026, against 4.9× a year earlier. Over the last 5 years it ranged from 0.8× to 43.1×, with a median of 4.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | −3.5 |
| 2025 | Dec 31, 2025 | 5.4× | −25.6 |
| 2024 | Dec 31, 2024 | 31.0× | +24.9 |
| 2023 | Dec 29, 2023 | 6.0× | +4.0 |
| 2022 | Dec 30, 2022 | 2.0× | −1.5 |
| 2021 | Dec 31, 2021 | 3.6× | −13.3 |
| 2020 | Dec 31, 2020 | 16.9× | – |
See a number that looks wrong?